Markets:

Overview

News

Currencies

International

Treasuries

Boston Scientific (NY:BSX)

78.03 +2.53 (+3.35%)

Streaming Delayed Price Updated: 1:34 PM EST, Feb 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Boston Scientific

< Previous 1 2 3 4 5 6 7 8 9

...

23 24 Next >

ResMed Among Top Stocks For Recent And Long-Term Profit Growth ↗

March 10, 2025

A Relative Strength Rating upgrade for ResMed shows improving technical performance. Will it continue?

Via Investor's Business Daily

What To Expect From CooperCompanies’s (COO) Q4 Earnings

March 05, 2025

Medical device company CooperCompanies (NASDAQ:COO) will be reporting results tomorrow after market close. Here’s what you need to know.

Via StockStory

Why the high growth investor may take a look at BOSTON SCIENTIFIC CORP (NYSE:BSX). ↗

March 05, 2025

Should you consider BOSTON SCIENTIFIC CORP (NYSE:BSX) for high growth investing? A fundamental and technical analysis of (NYSE:BSX).

Via Chartmill

Beyond The Numbers: 17 Analysts Discuss Boston Scientific Stock ↗

March 03, 2025

Via Benzinga

Boston Scientific To Acquire SoniVie For $400 Million, Expanding Hypertension Treatment Portfolio ↗

March 03, 2025

Boston Scientific will acquire SoniVie for up to $600 million on 100% basis, adding the TIVUS ultrasound system to its hypertension treatment pipeline. Deal closes in H1 2025.

Via Benzinga

1 Growth Stock with All-Star Potential and 2 to Brush Off

March 03, 2025

Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s...

Via StockStory

$1000 Invested In Boston Scientific 10 Years Ago Would Be Worth This Much Today ↗

February 25, 2025

Via Benzinga

What Does the Market Think About Boston Scientific? ↗

February 24, 2025

Via Benzinga

Top Stock Reports For Goldman Sachs, Progressive & Boston Scientific ↗

February 28, 2025

Today's Research Daily features new research reports on 16 major stocks, including The Goldman Sachs Group, Inc., The Progressive Corp. and Boston Scientific Corp., as well as micro-cap stock...

Via Talk Markets

Topics Stocks / Equities

Medical Devices & Supplies - Diversified Stocks Q4 Teardown: Stryker (NYSE:SYK) Vs The Rest

February 28, 2025

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at medical devices & supplies - diversified...

Via StockStory

Which S&P500 stocks are moving on Tuesday? ↗

February 25, 2025

Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Tuesday.

Via Chartmill

Explore the top gainers and losers within the S&P500 index in today's session. ↗

February 25, 2025

Curious about the S&P500 stocks that are in motion on Tuesday? Join us as we explore the top movers within the S&P500 index during today's session.

Via Chartmill

Earnings Scheduled For February 5, 2025 ↗

February 05, 2025

Via Benzinga

Deep Dive Into Boston Scientific Stock: Analyst Perspectives (7 Ratings) ↗

January 31, 2025

Via Benzinga

$1000 Invested In Boston Scientific 5 Years Ago Would Be Worth This Much Today ↗

January 29, 2025

Via Benzinga

Q4 Earnings Roundup: Baxter (NYSE:BAX) And The Rest Of The Medical Devices & Supplies - Diversified Segment

February 25, 2025

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how medical devices & supplies - diversified stocks fared in Q4,...

Via StockStory

Q4 Earnings Highs And Lows: Neogen (NASDAQ:NEOG) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks

February 24, 2025

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - diversified industry, including Neogen (NASDAQ:NEOG) and its peers.

Via StockStory

UroGen Pharma Ltd. (NASDAQ: URGN), CS Diagnostics Corp. (OTCQB: CSDX) and Boston Scientific (NYSE: BSX) Advancing Cancer Treatment Technology – More Stocks Inside

February 19, 2025

Via AB Newswire

Baxter Earnings: What To Look For From BAX

February 19, 2025

Healthcare company Baxter International (NYSE:BAX) will be reporting earnings tomorrow morning. Here’s what investors should know.

Via StockStory

What To Expect From Baxter’s (BAX) Q4 Earnings

February 12, 2025

Healthcare company Baxter International (NYSE:BAX) will be announcing earnings results tomorrow morning. Here’s what investors should know.

Via StockStory

ResMed Getting Close To Elite Stock Group Entry ↗

February 11, 2025

ResMed also boasts a 93 Composite Rating. The best growth stocks often have a 90 or higher Composite as they begin their biggest runs.

Via Investor's Business Daily

Q4 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Boston Scientific (NYSE:BSX)

February 10, 2025

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Boston Scientific (NYSE:BSX) and the best...

Via StockStory

GSK Surges 7% After Bumping Its 2031 Outlook To North Of $50 Billion ↗

February 05, 2025

GSK delivered a mixed fourth-quarter report Wednesday, but GSK stock surged on its long-term outlook for more than $50 billion in sales.

Via Investor's Business Daily

Boston Scientific Beats Its Own Fourth-Quarter Guidance On Cardiovascular Strength ↗

February 05, 2025

Boston Scientific stock dipped Wednesday, but the medtech company beat Wall Street's fourth-quarter forecasts.

Via Investor's Business Daily

Stocks Rebound, Google Eyes Worst Drop In A Year, Gold Shatters Fresh Records: What's Driving Markets Wednesday? ↗

February 05, 2025

Wall Street rose on Wednesday, with all major equity indices advancing as investors assessed the latest batch of corporate earnings and drew optimism from positive labor market data.

Via Benzinga

Boston Scientific Clocks 22% Jump In Q4 Sales On Strong Heart Devices, Profit And Guidance Exceeds Expectations ↗

February 05, 2025

Boston Scientific posted Q4 revenue of $4.56 billion, surpassing estimates. The company forecasts 2025 sales growth of up to 14.5% and EPS of $2.80-$2.87.

Via Benzinga

Zimmer Biomet (ZBH) To Report Earnings Tomorrow: Here Is What To Expect

February 05, 2025

Medical device company Zimmer Biomet (NYSE:ZBH) will be reporting earnings tomorrow before market hours. Here’s what investors should know.

Via StockStory

BD (BDX) To Report Earnings Tomorrow: Here Is What To Expect

February 05, 2025

Medical technology company Becton, Dickinson and Company (NYSE:BDX) will be announcing earnings results tomorrow before market open. Here’s what to look for.

Via StockStory

Earnings To Watch: Haemonetics (HAE) Reports Q4 Results Tomorrow

February 05, 2025

Blood products company Haemonetics (NYSE:HAE). will be announcing earnings results tomorrow before the bell. Here’s what to expect.

Via StockStory

Boston Scientific (NYSE:BSX) Reports Bullish Q4, Guides for Strong Sales Next Quarter

February 05, 2025

Medical device company Boston Scientific (NYSE:BSX) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 22.4% year on year to $4.56 billion. Guidance for next quarter’s...

Via StockStory

< Previous 1 2 3 4 5 6 7 8 9

...

23 24 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.